Sonoma Pharmaceuticals (SNOA) Revenue (2010 - 2025)

Sonoma Pharmaceuticals' Revenue history runs 16 years deep, the most recent figure standing at $4.3 million for Q4 2025.

• In Q4 2025, Revenue rose 22.03% year-over-year to $4.3 million; the TTM figure through Dec 2025 stood at $17.7 million (up 26.83% YoY), while the FY2025 annual figure was $14.3 million, up 12.19% from the prior year.
• Revenue was $4.3 million for Q4 2025 at Sonoma Pharmaceuticals, down from $5.6 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $5.6 million in Q3 2025 to a low of $2.2 million in Q1 2021.
• Historically, Revenue has averaged $3.5 million across 5 years, with a median of $3.4 million in 2023.
• The sharpest annual moves came in 2021 and 2025: Revenue sank 49.98% in 2021, then jumped 56.58% in 2025.
• A 5-year view of Revenue shows it stood at $2.9 million in 2021, then advanced by 1.45% to $2.9 million in 2022, then gained by 6.59% to $3.1 million in 2023, then increased by 13.58% to $3.6 million in 2024, then gained by 22.03% to $4.3 million in 2025.
• The last three Revenue figures came in at $4.3 million (Q4 2025), $5.6 million (Q3 2025), and $4.0 million (Q2 2025), per Business Quant data.